Find information on thousands of medical conditions and prescription drugs.

Valganciclovir

Valganciclovir hydrochloride (Valcyte®) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Hydrocodone
Vagifem
Valaciclovir
Valcyte
Valganciclovir
Valine
Valium
Valnoctamide
Valproate semisodium
Valproic acid
Valpromide
Valrelease
Valsartan
Valstar
Valtrex
Vancenase
Vanceril
Vancomycin
Vaniqa
Vanticon
Vecuronium bromide
Velcade
Velivet
Venlafaxine
Ventolin
Vepesid
Verapamil
Verelan
Vermox
Versed
Vfend
Viadur
Viagra
Vicoprofen
Vidarabine
Vidaza
Videx
Vigabatrin
Viloxazine
Vinblastine
Vincristine
Vinorelbine
Viomycin
Vioxx
Viracept
Viread
Visine
Vistide
Visudyne
Vitaped
Vitrase
Vivelle
Volmax
Voltaren
Voriconazole
Vosol
W
X
Y
Z

Administration

Orally, available in 450 mg pink tablets. Dosing is calculated to provide appropriate doses of ganciclovir; 900 mg of valganciclovir orally every 12 hours is equivalent to 5 mg per kilogram of body weight of intravenous ganciclovir, also every 12 hours.

Pharmacokinetics

  1. Oral bioavailability is approximately 60%. Fatty foods significantly increase the bioavailability and the peak level in the serum.
  2. It takes about 2 hours to reach maximum concentrations in the serum.
  3. Valganciclovir is eliminated as ganciclovir in the urine, with a half-life of about 4 hours in people with normal kidney function.

Side effects

  • Blood: neutropenia, anemia, low platelets. Myelosuppression is one of the main side effects that may limit prolonged use of valganciclovir.
  • Gastrointestinal: diarrhea, nausea, vomiting, abdominal pain.
  • Central nervous system: fever, headache, insomnia, paresthesia, and peripheral neuropathy.
  • Ocular: retinal detachment

Read more at Wikipedia.org


[List your site here Free!]


Low doses of valganciclovir sufficient for most recipients.(Nephrology) : An article from: Internal Medicine News $5.95 Pocket Pharma: Valganciclovir and Cytomegalovirus Infection $15.95
Valganciclovir hydrochloride (Valcyte[TM]): a new antiviral agent. (Medication Review). : An article from: Nephrology Nursing Journal $5.95

Valganciclovir Hydrochloride 60-mg/mL Oral Liquid
METHOD OF PREPARATION 1. Calculate the required quantity of each ingredient for the total amount to be prepared. 2. Accurately weigh and/or measure each ...
Stability of valganciclovir in extemporaneously compounded liquid formulations
Stability of valganciclovir in extemporaneously compounded liquid formulations. Henkin CC, Griener JC, Ten Eick AP. Am J Health Syst Pharm 2003;60:687-690.
Stability of valganciclovir in an extemporaneously compounded oral liquid
Stability of valganciclovir in an extemporaneously compounded oral liquid. Anaizi NH, Dentinger PJ, Swenson CF Am J Health Syst Pharm 2002;59:1267-- 1270. The procedure for compounding an oral susp
Easier option for CMV - HIV Digest - Brief Article
Oral treatment with valganciclovir (Valcyte) appears to be as effective as intravenous ganciclovir (Cytovene), according to the New England Journal of ...
Cytomegalovirus after kidney transplantation: a case review
Cytomegalovirus is the most common infectious complication in solid-organ transplant recipients. Despite the frequency of the problem, no commonly accepted ...
Pharmacogenomics and its applications
The Great Paracelsus (Philipus Aureolus Theophrastus Bombastus von Hohenheim-Paracelsus, 1493-1541) is remembered by toxicologists for his famous quote: ...
Metastatic foci of signet ring cell carcinoma in a tubular adenoma of the colon
We describe a case of adenomatous polyp of the colon that harbored small foci of signet ring cell carcinoma. The patient was a 64-year-old woman with end-stage renal disease and sepsis who underwent
Effective drugs against viral disease
Literature Review Drugs for Non-HIV viral infections. The Medical Letter 2002;44(1123):9-16 This issue updates recommendations regarding drugs for nonhuman ...

Home Contact Resources Exchange Links ebay